Literature DB >> 18836358

Instrumented slip reduction and fusion for painful unstable isthmic spondylolisthesis in adults.

Yizhar Floman1, Michael A Millgram, Ely Ashkenazi, Yossi Smorgick, Nahshon Rand.   

Abstract

BACKGROUND CONTEXT: Although in situ posterolateral fusion is considered the gold standard for surgical treatment of low-grade adult spondylolisthesis, correction of the sagittal translation by instrumented slip reduction is more controversial in adults; nevertheless it may delay adjacent level disc degeneration.
PURPOSE: The present study was undertaken to evaluate the safety and clinical outcome of operative instrumented slip reduction in 12 adults with isthmic spondylolisthesis accompanied by advanced disc degeneration at that level. STUDY
DESIGN: This study was a retrospective review of 12 consecutive lumbar or lumbosacral isthmic slip, which underwent operative slip reduction in our institute. PATIENT SAMPLE: All adult patients having operative instrumented slip reduction of isthmic spondylolisthesis from January 2000 to December 2005 were assessed. OUTCOME MEASURES: Outcome measures included the Oswestry Disability Index (ODI) for low back pain and the visual analog scale (VAS) of back and leg pain. Patient outcome was assessed by work status, participation in sports activities and intake of pain medications.
METHODS: Between January 2000 and December 2005, we performed slip reduction on 12 adults aged 28 to 62 years (average 47) with symptomatic lumbar or lumbosacral isthmic spondylolisthesis. The indications for surgery were long-standing low back and leg pain that had not responded to nonoperative management.
RESULTS: The vertebral slip ranged between 15% and 90% (average 34%). Radiologic evidence of adult slip progression was available in 5 patients, one had a de novo slip formation and the others had increased sagittal translation on flexion-extension lateral x-rays. All 12 patients underwent posterior decompression, pedicle screw fixation, slip reduction, and posterior lumbar interbody fusion. The slip was anatomically reduced by 100% in 5 patients and between 90% and 95% in 7 (average 95% for the group). X-rays revealed no evidence of instrumentation failure at a mean follow-up of 38 months (range: 18 to 72). Minimal loss of correction (5%) was observed in 2 cases. No neurologic complications were encountered. The mean preoperative ODI of 49 dropped to 12 postoperatively (range: 0 to 20). The mean preoperative VAS for back pain of 7.3 dropped to 1.6 after surgery (range: 0 to 3). The mean preoperative VAS for leg pain of 8 dropped to 1 after surgery (range: 0 to 4). Five patients were followed for more than 3 years: none had evidence of adjacent level disc disease.
CONCLUSIONS: Our results may support performing slip reduction in selected adults with isthmic spondylolisthesis.

Entities:  

Mesh:

Year:  2008        PMID: 18836358     DOI: 10.1097/BSD.0b013e31815b1abf

Source DB:  PubMed          Journal:  J Spinal Disord Tech        ISSN: 1536-0652


  14 in total

1.  An RCT study comparing the clinical and radiological outcomes with the use of PLIF or TLIF after instrumented reduction in adult isthmic spondylolisthesis.

Authors:  Er-Zhu Yang; Jian-Guang Xu; Xiao-Kang Liu; Gen-Yang Jin; Wenzhen Xiao; Bing-Fang Zeng; Xiao-Feng Lian
Journal:  Eur Spine J       Date:  2015-12-09       Impact factor: 3.134

2.  Single segment of posterior lumbar interbody fusion for adult isthmic spondylolisthesis: reduction or fusion in situ.

Authors:  Xiao-Feng Lian; Tie-Sheng Hou; Jian-Guang Xu; Bing-Fang Zeng; Jie Zhao; Xiao-Kang Liu; Er-Zhu Yang; Cheng Zhao
Journal:  Eur Spine J       Date:  2013-06-14       Impact factor: 3.134

3.  C1 lateral mass reduction screws for treating atlantoaxial dislocations: Bringing ease by modification.

Authors:  Deepak Kumar Singh; Vipul Pathak; Neha Singh; Rakesh Kumar Singh; Mohammad Kaif; Kuldeep Yadav
Journal:  J Craniovertebr Junction Spine       Date:  2022-06-13

Review 4.  Bilateral tubular minimally invasive surgery for low-dysplastic lumbosacral lytic spondylolisthesis (LDLLS): analysis of a series focusing on postoperative sagittal balance and review of the literature.

Authors:  Giuseppe M V Barbagallo; Mario Piccini; Abdulrazzaq Alobaid; Abdulaziz Al-Mutair; Vincenzo Albanese; Francesco Certo
Journal:  Eur Spine J       Date:  2014-09-17       Impact factor: 3.134

5.  Instrumented reduction of a fixed C1-2 subluxation using occipital and C2/C3 fixation: A case report.

Authors:  Clifton Meals; Rachel Harrison; Warren Yu; Joseph O'Brien
Journal:  Int J Spine Surg       Date:  2013-12-01

6.  Lever reduction using polyaxial screw and rod fixation system for the treatment of degenerative lumbar spondylolisthesis with spinal stenosis: technique and clinical outcome.

Authors:  Zu-De Liu; Xin-Feng Li; Lie Qian; Lian-Ming Wu; Li-Feng Lao; Han-Tao Wang
Journal:  J Orthop Surg Res       Date:  2015-02-15       Impact factor: 2.359

7.  No correlation between slip reduction in low-grade spondylolisthesis or change in neuroforaminal morphology and clinical outcome.

Authors:  H S Hagenmaier; Diyar Delawi; Nico Verschoor; F Oner; Job L C van Susante
Journal:  BMC Musculoskelet Disord       Date:  2013-08-19       Impact factor: 2.362

8.  A ball-slide-type interbody distractor is effective in posterior reduction and internal fixation for patients with mid- to high-grade isthmic spondylolisthesis enrolled in a randomized clinical trial.

Authors:  Pengfei Li; Zongmao Zhao; Nan Jia; Litao Wang; Zhaosheng Sun; Xianhui Jin
Journal:  Medicine (Baltimore)       Date:  2019-11       Impact factor: 1.817

9.  Interbody Fusion in Low Grade Lumbar Spondylolsithesis: Clinical Outcome Does Not Correalte with Slip Reduction and Neural Foraminal Dimension.

Authors:  Ujjwal K Debnath; Atanu Chatterjee; Jeffrey R McConnell; Deepak K Jha; Tapas Chakraburtty
Journal:  Asian Spine J       Date:  2016-04-15

10.  Effect of bone graft granule volume on postoperative fusion after lumber spinal internal fixation: A retrospective analysis of 82 cases.

Authors:  Jianxue Hao; Chongchao Yan; Suoli Liu; Pengfa Tu
Journal:  Pak J Med Sci       Date:  2018 Sep-Oct       Impact factor: 1.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.